Thrombosis
Long-term PROTECT-AF analysis: Watchman attains efficacy superiority over warfarin in AF
May 10, 2013 10:00 EDT
The Watchman left-atrial appendage occluder had previously been found noninferior to warfarin in patients with nonvalvular atrial fibrillation; now, with an average of 45 months of follow-up, it's not only noninferior, it's superior, by some statistical measures.

Denver, CO - A long-term follow-up analysis of the PROTECT-AF trial shows—in contrast to shorter-term analyses based on the trial—that left atrial appendage (LAA) closure with the Watchman (Boston Scientific) is superior to warfarin with respect to all-cause and CV mortality and hemorrhagic stroke in patients with nonvalvular atrial fibrillation and stroke risk factors [1].
Read full article »

Arrhythmia/EP
HRS members support charitable ICD/pacemaker donation for reuse overseas
May 16, 2013 17:30 EDT

Arrhythmia/EP
Dabigatran "real-life" results suggest caution needed
May 15, 2013 17:15 EDT

Arrhythmia/EP
No clinical gain, more risk: Preference for dual- vs single-chamber ICD again questioned
May 15, 2013 16:15 EDT

Interventional/Surgery
Gene-mutation discovery in congenital heart disease spells major shift in care
May 15, 2013 09:15 EDT

Arrhythmia/EP
How close am I? Shocks decline when ICD programmers reminded of evidence-based settings
May 14, 2013 10:45 EDT

Arrhythmia/EP
Repeat ablation wins out over antiarrhythmic agents for recurrent paroxysmal AF
May 13, 2013 15:45 EDT

From the blogsView all »
Trials and Fibrillations with
Dr John Mandrola
Mandrola
Disagreeing with an influential thought leader on ICD use
May 15, 2013 10:52 EDT
Editorial programs
Debate and dialogue between top cardiovascular specialists, produced by
theheart.org's editorial team
View all »
Healthcare reform and cardiology: An even-keeled update
Healthcare reform and cardiology: An even-keeled update
May 2, 2013 08:45 EDT
Breaking embargo: PREVAIL and how we publish data from clinical trials
Breaking embargo: PREVAIL and how we publish data from clinical trials
Apr 12, 2013 16:33 EDT
ACC 2013 research highlights: A slideshow presentation
ACC 2013 research highlights: A slideshow presentation
4 COMMENTS - Mar 19, 2013 10:00 EDT
View all »Collections
heartwire collections groups our most compelling cardiology news coverage and editorial content by popular themes. Find everything on a single topic, in one place, with one click.
Antiplatelet up-and-comers
The quest for ever-more effective drugs to decrease platelet aggregation and reduce the...
Aspirin and primary prevention
Long considered an essential agent for primary cardiovascular disease prevention...
Dabigatran: A chronology
The presentation of the RE-LY results at the 2009 ESC meeting, showing that dabigatran...
MRIs and implantable device safety
Magnetic resonance imaging tests are increasingly being used for diagnosing forms of...
Drugs, money, and glory: Is cancer beating cardiovascular disease?
Heart disease still tops the charts as the number-one killer in most developed...
ECG of the month (view all)
Why Does the QRS Morphology Change?
Why Does the QRS Morphology Change?
May 13, 2013 15:55 EDT
Is this sinus tachycardia?
Is this sinus tachycardia?
Apr 10, 2013 16:28 EDT
Resource Center (view all)

What's New